Technological Breakthrough in Intelligent IV-Admixture Center: Integration of Automation and AI Reshapes IV Medication Preparation
The Infection Control Division of Shinva Medical Instrument Co., Ltd. has made important progress in centralized intravenous medication preparation, launching an integrated solution for the Intelligent IV-Admixture Center.
Built on a platform-oriented technical architecture, this solution integrates automated equipment, AI visual recognition, precision mechanical control and information systems to form an intelligent closed loop covering drug storage, sorting, preparation and inspection. The self-developed cytostatic drug compounding machine automatically performs buffering, injection, weighing, dissolution and aspiration in a Class-100 clean environment. Integrated with air purification and waste recovery functions, it ensures fully enclosed and standardized preparation of chemotherapeutic drugs, effectively preventing occupational exposure and cross-contamination.
Powered by AI vision and deep learning, the system conducts real-time verification of drug labels and liquid aspiration processes to reduce medication errors. High-precision sensors and closed-loop control enable adaptability to special-shaped vials and diverse packaging formats.
In practical deployment, automation cuts the preparation time per batch to a fraction of that required by conventional workflows, greatly easing patients’ waiting time. AI-enabled review brings the error rate close to zero, delivering quantifiable safeguards for medication safety. Automatic data upload across the whole workflow creates a complete traceability chain from medical order to infusion, supporting pharmaceutical management and audit requirements. In addition, it frees pharmacists and nursing staff from repetitive manual tasks, allowing them to focus on clinical consultation and prescription review, and advancing the transformation of pharmaceutical services.